Biography
Sarah Schwarz is an associate in Weil’s Technology & IP Transactions practice and is based in New York. Sarah participates in advising Firm clients in a variety of matters relating to the licensing, acquisition, development, sale, use and commercial exploitation of intellectual property and technology. She also participates in advising clients regarding privacy and data security issues in the context of corporate transactions.
Sarah has been part of the teams advising:
- ITE Management, L.P. in a strategic minority investment from funds managed by Blackstone Credit & Insurance
- Sanofi in its $9.5 billion acquisition of Blueprint Medicines
Sarah received her J.D., magna cum laude, from The University of Pennsylvania Carey Law School, where she was Senior Editor of the University of Pennsylvania Law Review, and her B.A., summa cum laude, from The University of Pennsylvania.